PCI makes fourth acquisition outside of US

Lilly completes $1.6bn acquisition of ARMO BioSciences
Credit: Shutterstock.com/ ASDF_MEDIA

PCI Pharma Services (PCI) has made its first acquisition outside of the US in as many years with the addition or Ireland’s Millmount Healthcare.

Millmount, a pharmaceutical and healthcare contract packaging services provider, has invested in expanding its potent compound packaging capability, recently opening a new, state-of-the-art high potent, high containment packaging facility.

PCI currently supports medicines destined to over 100 countries around the world.  This acquisition will bolster its Irish presence and customer reach, the company said.

“With Millmount’s geographic presence in the European Union, we also see tremendous value in helping mitigate any uncertainty brought about by the evolving Brexit situation,” said Bill Mitchell, PCI President and CEO.

With the addition of Millmount, PCI will now feature 18 facilities across North America and Europe, employing over 3,200 highly trained associates.

The acquisition of Millmount continues PCI’s strategy of continued investment and expansion of services.